We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$586M
AUM Growth
-$19.4M
Cap. Flow
-$11.6M
Cap. Flow %
-1.98%
Top 10 Hldgs %
17.48%
Holding
250
New
15
Increased
23
Reduced
114
Closed
18

Top Buys

Rank Stock Value
1
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$4.5M
2
GAMB
Gambling.com
GAMB
+$4.05M
3
AZN icon
AstraZeneca
AZN
+$3.62M
4
GPN icon
Global Payments
GPN
+$3.4M
5
OWL icon
Blue Owl Capital
OWL
+$2.96M

Top Sells

Rank Stock Value
1
WAB icon
Wabtec
WAB
+$4.27M
2
ABBV icon
AbbVie
ABBV
+$3.73M
3
BX icon
Blackstone
BX
+$3.24M
4
GTLB icon
GitLab
GTLB
+$2.72M
5
MDB icon
MongoDB
MDB
+$2.58M

Sector Composition

Rank Sector Weight
1 Technology 36.08%
2 Industrials 13.65%
3 Energy 8.19%
4 Healthcare 7.99%
5 Consumer Discretionary 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLBE icon
151
Global E Online
GLBE
$6.08B
$275K 0.05%
6,914
– –
AMGN icon
152
Amgen
AMGN
$203B
$251K 0.04%
935
– –
IEI icon
153
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$248K 0.04%
2,194
+115
+6% +$13.2K
BDX icon
154
Becton Dickinson
BDX
$43.1B
$245K 0.04%
947
– –
DHR icon
155
Danaher
DHR
$135B
$242K 0.04%
1,099
+26
+2% +$5.8K
TMO icon
156
Thermo Fisher Scientific
TMO
$211B
$238K 0.04%
470
+19
+4% +$10.1K
EXFY icon
157
Expensify
EXFY
$166M
$232K 0.04%
71,252
-537
-0.7% -$2.9K
VTI icon
158
Vanguard Total Stock Market ETF
VTI
$654B
$226K 0.04%
1,064
-126
-11% -$27.9K
MNDY icon
159
monday.com
MNDY
$3.27B
$224K 0.04%
1,405
-239
-15% -$40.1K
CI icon
160
Cigna
CI
$76.6B
$223K 0.04%
779
– –
ADBE icon
161
Adobe
ADBE
$89.5B
$220K 0.04%
432
– –
RSG icon
162
Republic Services
RSG
$66.7B
$215K 0.04%
1,512
– –
GD icon
163
General Dynamics
GD
$105B
$214K 0.04%
967
– –
SHOP icon
164
Shopify
SHOP
$148B
$214K 0.04%
3,913
– –
GLW icon
165
Corning
GLW
$126B
$213K 0.04%
7,002
– –
MDT icon
166
Medtronic
MDT
$107B
$208K 0.04%
2,660
– –
SYK icon
167
Stryker
SYK
$127B
$206K 0.04%
754
– –
PINS icon
168
Pinterest
PINS
$12.4B
$204K 0.03%
7,565
– –
STZ icon
169
Constellation Brands
STZ
$22.2B
$204K 0.03%
+812
New +$212K
ROP icon
170
Roper Technologies
ROP
$36.3B
$204K 0.03%
421
– –
ENB icon
171
Enbridge
ENB
$124B
$200K 0.03%
5,968
– –
EGRX
172
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$189K 0.03%
12,000
– –
MPT
173
Medical Properties Trust
MPT
$2.89B
$81.8K 0.01%
15,000
– –
DNN icon
174
Denison Mines
DNN
$2.63B
$25.5K ﹤0.01%
15,448
– –
AMD icon
175
Advanced Micro Devices
AMD
$851B
– –
-1,784
Closed -$203K
4 5 6
7
8

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q3 2023 Portfolio in Review

As of Q3 2023, Stanley-Laman Group held 250 positions worth $586M, down 3.2% from $605M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Stanley-Laman Group's Q3 2023 filing shows 15 new, 23 increased, 114 reduced and 18 closed positions. Its largest new stake was AstraZeneca: 26,476 shares worth $3.59M. The largest sale was Wabtec, an estimated $4.27M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Industrials and Energy.

  • Stanley-Laman Group's largest Q3 2023 buy was AstraZeneca: 26,476 shares worth $3.59M.
  • Stanley-Laman Group added most to HashiCorp, Inc. Class A Common Stock in Q3 2023, an estimated $4.5M increase.
  • Stanley-Laman Group's biggest Q3 2023 reduction was AbbVie, cutting an estimated $3.73M.
  • Stanley-Laman Group fully exited Wabtec in Q3 2023, selling an estimated $4.27M.
  • Stanley-Laman Group's ten largest holdings make up 17% of its $586M portfolio in Q3 2023.
  • Stanley-Laman Group opened 15 new positions and closed 18 in Q3 2023.
  • Stanley-Laman Group's portfolio value fell 3.2% quarter-over-quarter to $586M.

Based on Stanley-Laman Group's 13F filing for Q3 2023, filed 16 Oct 2023.